From: jeffrey E. <[email protected]> Sent: Sunday, November 16, 2014 9:41 AM To: Joi Ito Subject: Re: GPCR we should just know ore about 2nd round, so we are not dil=ted On =at, Nov 15, 2014 at 6:52 PM, Joi Ito • wrot=: Mo=e background on the science. The investment vehicle is basically a holding=company for the technology that will spin out in various applications incl=ding biomedical, etc. Jeffrey, this is being done in Ne=l Gershenfeld's Lab, CBA. -Joi Begin forwarded message: =br> Hi Joi,<=iv style="font-family:Helvetica;font-size:12px;font-style:normal;font-variant:normal;font- weight:normal;letter-spacing:normal;line-height:normal;te=t-align:starttext-indent:0px;text-transform:none;white- space:normal;word-=pacing:0px"> I just hired a new postdoc dedicated f=r this odorant-receptor-based sensor project. He just arrived last w=ek. However, I will ask Dr. Andreas Mershin if his polymer smelling =evice is good to give a try. Ou= water-soluble GPCR project got a big breakthrough last week. Here i= a deck of slides and message I wrote to Teijin Head of Strucutral Biology= I visited there and gave a talk on Wednesday. I just return to Bost=n last night. Dann= Hillis will invest in OH2Laboratories. He was here visiting =e and very excited. Shu uan Zhan «= hrefr"maiRo: <mailto ar et=" blank" : David, Marc Rioult Re: Thank you =ear Midori, I was very pleased to meet you again yesterday=at Teijin. This was my 4th time visiting Teijin. =div style="font-family:ArialMT"> Please find the attached slides of my talk at Teijin yesterday. =ope you can understand our recent breakthrough to design water-soluble GPC=s and all other membrane proteins as well as all aggregated proteins.4,=A0 EFTA_R1_01779011 EFTA02594854